{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:40:31Z","timestamp":1780987231671,"version":"3.54.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1136\/ijgc-2023-004582","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T05:15:57Z","timestamp":1709529357000},"page":"393-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gynecological sarcomas, surgical management: primary, metastatic, and recurrent disease"],"prefix":"10.1016","volume":"34","clinical-trial-number":[{"clinical-trial-number":"nct04307277","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8545-4700","authenticated-orcid":false,"given":"Gwenael","family":"Ferron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bataillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-3536","authenticated-orcid":false,"given":"Alejandra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Chibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004582_bb0010","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.18632\/oncotarget.26803","article-title":"Role of surgery in gynaecological sarcomas","volume":"10","author":"Ghirardi","year":"2019","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2023-004582_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-023-02161-1","article-title":"Trends in incidence, survival and initial treatments of gynecological sarcoma: a retrospective analysis of the United States subpopulation","volume":"23","author":"He","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1136\/ijgc-2023-004582_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.path.2019.01.004","article-title":"Uterine mesenchymal tumors: update on classification, staging, and molecular features","volume":"12","author":"Parra-Herran","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"10.1136\/ijgc-2023-004582_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.path.2022.02.009","article-title":"Update on mesenchymal lesions of the lower female genital tract","volume":"15","author":"Croce","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"10.1136\/ijgc-2023-004582_bb0030","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0035","doi-asserted-by":"crossref","first-page":"iv79","DOI":"10.1093\/annonc\/mdy310","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0040","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/annonc\/mdz124","article-title":"Surgery in reference centers improves survival of sarcoma patients: a nationwide study","volume":"30","author":"Blay","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0045","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.211658","article-title":"MRI evaluation of uterine masses for risk of leiomyosarcoma: a consensus statement","volume":"306","author":"Hindman","year":"2023","journal-title":"Radiology"},{"key":"10.1136\/ijgc-2023-004582_bb0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ygyno.2003.10.044","article-title":"The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999)","volume":"92","author":"Dinh","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0055","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/PAS.0000000000001746","article-title":"Intraoperative frozen section biopsy of uterine smooth muscle tumors: a clinicopathologic analysis of 112 cases with emphasis on potential diagnostic pitfalls","volume":"45","author":"Lok","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2023-004582_bb0060","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2023-004582_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmig.2010.10.001","article-title":"AAGL position statement: route of hysterectomy to treat benign uterine disease","volume":"18","author":"AAGL Advancing Minimally Invasive Gynecology Worldwide","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1136\/ijgc-2023-004582_bb0070","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/AOG.0b013e3181c33c72","article-title":"ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004582_bb0075","article-title":"Surgical approach to hysterectomy for benign gynaecological disease","volume":"8","author":"Pickett","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2023-004582_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jogoh.2018.05.015","article-title":"Can the risks associated with uterine sarcoma morcellation really be prevented? Overview of the role of uterine morcellation in 2018","volume":"47","author":"Rousseau","year":"2018","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1136\/ijgc-2023-004582_bb0085","doi-asserted-by":"crossref","first-page":"101992","DOI":"10.1016\/j.jogoh.2020.101992","article-title":"Incidence of occult uterine sarcoma and other unexpected pathologies in patients having surgery for presumed myomas: a retrospective observational study","volume":"50","author":"M\u00fchlenbrock","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1136\/ijgc-2023-004582_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2008.02.026","article-title":"The utility of preoperative endometrial sampling for the detection of uterine sarcomas","volume":"110","author":"Bansal","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0095","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1245\/s10434-022-12799-0","article-title":"Percutaneous uterine needle biopsy with microscopic and array-CGH analyses for preoperative sarcoma diagnosis in patients with suspicious myometrial tumors on MRI: a prospective pilot study (SARCGYN)","volume":"30","author":"Smadja","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/modpathol.2015.3","article-title":"Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions","volume":"28","author":"Croce","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2023-004582_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bulcan.2023.01.009","article-title":"Uterine leiomyosarcoma - French guidelines from the GSF\/NETSARC and TMRG groups","volume":"110","author":"Collineau","year":"2023","journal-title":"Bull Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.0.CO;2-4","article-title":"Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction","volume":"82","author":"Sood","year":"1998","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0115","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/cam4.5015","article-title":"CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: results from the ISG-STS 1001 study","volume":"12","author":"Frezza","year":"2023","journal-title":"Cancer Med"},{"key":"10.1136\/ijgc-2023-004582_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/gcc.22703","article-title":"CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond","volume":"58","author":"Chibon","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02787-x","article-title":"Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome","volume":"11","author":"Benhaddou","year":"2021","journal-title":"Sci Rep"},{"key":"10.1136\/ijgc-2023-004582_bb0130","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/cam4.615","article-title":"Outcomes of unplanned sarcoma excision: impact of residual disease","volume":"5","author":"Charoenlap","year":"2016","journal-title":"Cancer Med"},{"key":"10.1136\/ijgc-2023-004582_bb0135","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ejso.2006.05.005","article-title":"Prospective evaluation of quality of surgery in soft tissue sarcoma","volume":"32","author":"Stoeckle","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0140","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/annonc\/mdr610","article-title":"Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions","volume":"23","author":"Ray-Coquard","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0145","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1245\/s10434-017-6031-z","article-title":"Update on the Querleu-Morrow classification of radical hysterectomy","volume":"24","author":"Querleu","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","article-title":"Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation","volume":"145","author":"Ricci","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0155","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1055\/a-1897-5124","article-title":"Sarcoma of the uterus. Guideline of the DGGG, OEGGG and SGGG (S2K-level, AWMF Registry No. 015\/074, April 2021)","volume":"82","author":"Denschlag","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1136\/ijgc-2023-004582_bb0160","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231157645","article-title":"Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group","volume":"15","author":"P\u00e9rez-Fidalgo","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0165","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/ijgc-2021-002649","article-title":"How to avoid peritoneal tumor spillage during total abdominal hysterectomy in uterine cancers with cervical invasion","volume":"31","author":"Leray","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0170","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ijgc-2020-001745","article-title":"Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas","volume":"30","author":"Benito","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0175","doi-asserted-by":"crossref","first-page":"101589","DOI":"10.1016\/j.suronc.2021.101589","article-title":"Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database","volume":"38","author":"Nasioudis","year":"2021","journal-title":"Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejogrb.2022.10.013","article-title":"Prognostic significance of lymphadenectomy in uterine leiomyosarcomas and endometrial stromal sarcomas: systematic review and meta-analysis","volume":"279","author":"Li","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2023-004582_bb0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000658-199301000-00012","article-title":"Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients","volume":"217","author":"Fong","year":"1993","journal-title":"Ann Surg"},{"key":"10.1136\/ijgc-2023-004582_bb0190","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.suronc.2018.07.012","article-title":"Neutrophil\/lymphocyte ratio is associated with survival in synovial sarcoma","volume":"27","author":"Garc\u00eda-Ortega","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0195","article-title":"Proximal-type epithelioid sarcoma of vulva - case series of a rare tumor","volume":"39","author":"Dash","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2023-004582_bb0200","first-page":"100268","article-title":"Should metastatic lymph nodes be considered at the same clinical stage as distant metastasis in soft tissue sarcomas","volume":"26","author":"Garcia-Ortega","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1136\/ijgc-2023-004582_bb0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"Kapp","year":"2008","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0090-8258(03)00478-5","article-title":"Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus","volume":"91","author":"Leitao","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.05.036","article-title":"Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study","volume":"146","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0225","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/cancers12082112","article-title":"Epithelioid sarcoma-from genetics to clinical practice","volume":"12","author":"Czarnecka","year":"2020","journal-title":"Cancers"},{"key":"10.1136\/ijgc-2023-004582_bb0230","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1245\/s10434-009-0393-9","article-title":"Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas","volume":"16","author":"Maduekwe","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0235","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ejso.2007.07.014","article-title":"Sentinel node biopsy in synovial sarcoma","volume":"34","author":"Tunn","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0240","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0245","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bulcan.2023.03.003","article-title":"Endometrial stromal sarcoma: French Guidelines from the French Sarcoma Group and the Rare Malignant Gynecologic Tumors Group [in French]","volume":"110","author":"Lebreton","year":"2023","journal-title":"Bull Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2018.03.008","article-title":"Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: a multicenter review","volume":"149","author":"Stewart","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0255","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bulcan.2023.04.017","article-title":"Uterine adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group [in French]","volume":"110","author":"Karabajakian","year":"2023","journal-title":"Bull Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0260","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0265","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2013.12.032","article-title":"Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases","volume":"132","author":"Bai","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0270","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200255","article-title":"Aggressive pelvic angiomyxoma and its mimics: can imaging be the guiding light?","volume":"93","author":"Kumar","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1136\/ijgc-2023-004582_bb0275","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/IGC.0b013e3182843063","article-title":"Conservative en bloc surgery for aggressive angiomyxoma achieves good local control: analysis of 14 patients from a single institution","volume":"23","author":"Coppola","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0280","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1634\/theoncologist.2018-0338","article-title":"Treatment outcomes and sensitivity to hormone therapy of aggressive angiomyxoma: a multicenter, international, retrospective study","volume":"24","author":"Fuc\u00e0","year":"2019","journal-title":"Oncologist"},{"key":"10.1136\/ijgc-2023-004582_bb0285","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2017.54","article-title":"Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model","volume":"30","author":"Demicco","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2023-004582_bb0290","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejso.2007.06.006","article-title":"Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients","volume":"34","author":"Bonvalot","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0295","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejca.2014.11.019","article-title":"Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients","volume":"51","author":"Colombo","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261657","article-title":"Cryotherapy in extra-abdominal desmoid tumors: a systematic review and meta-analysis","volume":"16","author":"Vora","year":"2021","journal-title":"PLoS One"},{"key":"10.1136\/ijgc-2023-004582_bb0305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/CCO.0000000000000854","article-title":"Desmoid tumors: who, when and how to treat","volume":"34","author":"Mikhael","year":"2022","journal-title":"Curr Opin Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0310","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0190-9622(97)70179-8","article-title":"Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread","volume":"37","author":"Ratner","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ijgc-2023-004582_bb0315","first-page":"780","article-title":"Treatment of dermatofibroma sarcoma protuberans using modified Mohs micrographic surgery: no recurrences and smaller defects","volume":"34","author":"Hancox","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1136\/ijgc-2023-004582_bb0320","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/IGC.0000000000000239","article-title":"Gynecologic Cancer Intergroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract","volume":"24","author":"Friedlander","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2010.07.001","article-title":"Long-term outcome and natural history of uterine adenosarcomas","volume":"119","author":"Arend","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0330","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.10.022","article-title":"Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence","volume":"135","author":"Carroll","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0335","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mds545","article-title":"A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group","volume":"24","author":"Pautier","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0340","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cncr.27942","article-title":"Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005)","volume":"119","author":"Hensley","year":"2013","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0345","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00454","article-title":"Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: a phase III NRG Oncology\/Gynecologic Oncology Group study","volume":"36","author":"Hensley","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0350","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ygyno.2007.01.031","article-title":"A multi-institutional review of outcomes of endometrial stromal sarcoma","volume":"105","author":"Leath","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult uterine sarcoma and leiomyosarcoma: incidence of and survival associated with morcellation","volume":"127","author":"Raine-Bennett","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004582_bb0360","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/IGC.0b013e3181c9e289","article-title":"Metastatic uterine leiomyosarcomas: a single-institution experience","volume":"20","author":"Bernstein-Molho","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004582_bb0365","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","article-title":"Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma","volume":"106","author":"Giuntoli","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0370","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/annonc\/mdp485","article-title":"Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy","volume":"21","author":"Penel","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0375","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.athoracsur.2008.09.036","article-title":"Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach?","volume":"87","author":"Gossot","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1136\/ijgc-2023-004582_bb0380","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejso.2005.04.010","article-title":"Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis","volume":"31","author":"Bonvalot","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2023-004582_bb0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening","volume":"38","author":"Chompret","year":"2001","journal-title":"J Med Genet"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:29:36Z","timestamp":1753234176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24013264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1048891X24013264"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004582","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gynecological sarcomas, surgical management: primary, metastatic, and recurrent disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}